Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Chimeric antigen receptor produces complete responses and long-term persistence ...
Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in ...
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
T cells engineered with chimeric antigen receptor targeting CD19 produce signifi...
Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Removal of alpha/beta T cells and of CD19 B cells in children With acute leuka...
Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta  T cells and of CD19  B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013
Transplantation and short telomeres increase the risk of cognitive impairment
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California
Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California )
8 Dec 2013
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regre...
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Equality of access to transplant for ethnic minority patients
Dr Robert Lown - University College London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - University College London, UK )
7 Dec 2013
Encouraging outcomes in older patients following nonmyeloablative haploidentical...
Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation ( Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
7 Dec 2013
Use of autologous stem cell transplant in multiple myeloma
Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy
Use of autologous stem cell transplant in multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )
19 Jun 2013
Durable survival benefit for thalidomide consolidation in multiple myeloma post ...
Dr Anna Kalff - Alfred Hospital, Melbourne, Australia
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT ( Dr Anna Kalff - Alfred Hospital, Melbourne, Australia )
6 Apr 2013
Myeloma UK
Eric Low - Chief Executive, Myeloma UK
Myeloma UK ( Eric Low - Chief Executive, Myeloma UK )
6 Apr 2013
Hot topics at IMW 2013 - interactive discussion
Prof Philippe Moreau, Prof Jesus San Miguel
Hot topics at IMW 2013 - interactive discussion ( Prof Philippe Moreau, Prof Jesus San Miguel )
6 Apr 2013